Structure of CG428

CRBN-based TRK kinase fusion prot. degrader

degrad. of mult. TRK fusions (e.g. TPM3-TRKA)

from functionalization of lit. TRK inhibitor

J. Med. Chem., Oct. 15, 2020

Cullgen Inc., San Diego, CA / Shanghai, CN

CG428 (Cullgen CRBN-based TRK kinase fusion protein degrader)


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.